NASDAQ:SLS SELLAS Life Sciences Group (SLS) Institutional Ownership $1.71 0.00 (0.00%) (As of 06/5/2023 ET) Add Compare Share Share Today's Range$1.67▼$1.7450-Day Range$1.39▼$6.1552-Week Range$1.17▼$5.58Volume146,227 shsAverage Volume347,273 shsMarket Capitalization$48.48 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Institutional OwnershipProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage10.65%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$16.15 MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$5.43 M Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2023State Street Corp97,129$0.14M0.0%+35.4%0.343% 5/15/2023Equitable Holdings Inc.130,000$0.19M0.0%+15.0%0.459% 5/12/2023Dimensional Fund Advisors LP31,304$45K0.0%-46.6%0.110% 5/11/2023Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% 2/15/2023Virtu Financial LLC18,379$43K0.0%N/A0.089% 2/15/2023Millennium Management LLC61,179$0.14M0.0%+146.9%0.298% 2/13/2023Wells Fargo & Company MN16,140$38K0.0%+44.9%0.079% 2/13/2023Geode Capital Management LLC188,066$0.44M0.0%+30.0%0.915% 2/9/2023Dimensional Fund Advisors LP58,592$0.14M0.0%N/A0.285% 1/18/2023Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022State Street Corp58,206$0.12M0.0%+13.6%0.283% 11/15/2022Two Sigma Investments LP53,685$0.11M0.0%+149.8%0.261% 11/15/2022Empery Asset Management LP308,466$0.62M3.7%-66.8%1.501% 11/14/2022Renaissance Technologies LLC22,400$45K0.0%-33.8%0.109% 8/13/2022Renaissance Technologies LLC33,838$75K0.0%N/A0.165% 6/7/2022Bank of America Corp DE21,656$0.15M0.0%-31.9%0.105% 5/16/2022State Street Corp51,236$0.34M0.0%+36.7%0.249% 5/16/2022Prelude Capital Management LLC31,125$0.21M0.0%N/A0.152% 2/14/2022GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022Equitable Holdings Inc.102,000$0.56M0.0%+2.0%0.642% 11/12/2021Jump Financial LLC14,627$0.13M0.0%N/A0.092% 11/12/2021Equitable Holdings Inc.100,000$0.92M0.0%+6.0%0.630% 11/12/2021Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021Marshall Wace LLP84,544$0.94M0.0%+63.0%0.533% 8/17/2021Price T Rowe Associates Inc. MD15,500$0.17M0.0%-42.8%0.103% 8/16/2021Morgan Stanley15,499$0.17M0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$0.12M0.0%-18.3%0.071% 8/16/2021State Street Corp37,468$0.42M0.0%N/A0.248% 8/16/2021Marshall Wace LLP84,544$0.94M0.0%+63.0%0.560% 8/13/2021Northern Trust Corp24,605$0.27M0.0%+35.9%0.163% 8/13/2021Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021Dimensional Fund Advisors LP20,320$0.23M0.0%+31.9%0.135% 8/12/2021Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021Bank of New York Mellon Corp20,332$0.23M0.0%+30.3%0.135% (Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, 24 institutional investors and hedge funds held shares of SELLAS Life Sciences Group. The most heavily invested institutionals were Vanguard Group Inc. ($6.87M), Highbridge Capital Management LLC ($2.58M), Bank of Montreal Can ($1.43M), Marshall Wace LLP ($0.94M), Empery Asset Management LP ($0.62M), Geode Capital Management LLC ($0.44M), and Northern Trust Corp ($0.27M).Learn more on SLS's institutional investors. What percentage of SELLAS Life Sciences Group stock is owned by institutional investors? 10.65% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group stock? Of the 20 institutional investors that purchased SELLAS Life Sciences Group stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($1.81M), Vanguard Group Inc. ($0.15M), Bank of Montreal Can ($0.11M), State Street Corp ($83.61K), Geode Capital Management LLC ($82.24K), Marshall Wace LLP ($65.37K), and Dimensional Fund Advisors LP ($63.50K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 2,606,934 shares in the last 24 months. This purchase volume represents approximately $25.77M in transactions. Which SELLAS Life Sciences Group major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Empery Asset Management LP ($0.62M), Dimensional Fund Advisors LP ($27.29K), Price T Rowe Associates Inc. MD ($11.60K), Renaissance Technologies LLC ($11.44K), Bank of America Corp DE ($10.14K), and Pinz Capital Management LP ($2.40K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 682,388 shares in the last 24 months. This volume of shares sold represents approximately $5.74M in transactions. Related Companies: NextCure Major Shareholders Assembly Biosciences Major Shareholders MEI Pharma Major Shareholders Enlivex Therapeutics Major Shareholders NRx Pharmaceuticals Major Shareholders Mustang Bio Major Shareholders Carisma Therapeutics Major Shareholders Sensei Biotherapeutics Major Shareholders Nabriva Therapeutics Major Shareholders ASLAN Pharmaceuticals Major Shareholders This page (NASDAQ:SLS) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.